Edward Cloake

Director, Immunology

Edward is a Director in Bioassay team at Abzena. He specialises in Immunogenicity with a successful track record of delivering immunogenicity risk assessment assays for a broad range of protein biotherapeutics.  Edward has over 17 years’ experience in the pre-clinical immunogenicity assessment of biologics. He leads a team that utilizes a range of assays to evaluate the presence of potential T cell epitopes, and subsequent mitigation strategies to de-risk candidates.